Health TrialsbyHealthPanel

Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis

ConditionsLocal InjectionBotulinium Toxin-AChildrenDysfunctional VoidingRefractory Nocturnal Eneuresis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorTanta University

About this trial

The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with :

A-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children < 18 years.

Both sexes.

Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment.

Disqualifiers

Bleeding disorders.

Neuromusclar disorder(e.g.,Myasthenia gravis).

Patients who are not fit for anaesthesia.

Active urinary tract infection (UTI).

Trial design

Design model

Single group

Treatments tested in this trial

  • Botulinium Toxin-A

    Drug

    Patients will be injected with botulinium toxin-A

Treatment groups

64 Participants
are divided into 1 treatment group
Group A: Study groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Success rate

Success rate regarding improvement of clinical symptoms will be recorded.

Time frame
24 hours postoperatively

Secondary outcomes

1

Incidence of complications

Incidence of complications will be recorded.

Time frame
24 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tanta University

Lead sponsor

Source ClinicalTrials.gov
Apply now